Quantcast

Grand Canyon Times

Wednesday, November 27, 2024

FDA conducted third lowest number of inspections on Biologics companies in Arizona during Q3 2023

Webp wpqolpnrcij8e8mt9jfg90exrory

Mark Raza Principal Deputy Chief Counsel - FDA | Official Website

Mark Raza Principal Deputy Chief Counsel - FDA | Official Website

In the third quarter of 2023, two Biologics companies received two FDA inspections in Arizona, according to the U.S. Food and Drug Administration (FDA).

This was the third lowest number of inspections per type of company made by the FDA in Arizona, equalling 3.7% of all inspections in the third quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in Arizona During Q3 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products2----
Compliance: Devices41--
Drug Quality Assurance--1--
Food Composition, Standards, Labeling and Econ23--
Foodborne Biological Hazards3161
Human Cellular, Tissue, and Gene Therapies1----
Monitoring of Marketed Animal Drugs, Feed, and Devices4----
Postmarket Assurance: Devices5----
Tobacco Post-Market Activities1--1

MORE NEWS